Curasan AG | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
5,831.00
5,993.00
5,619.00
6,504.00
6,795.00
Cost of Goods Sold (COGS) incl. D&A
5,323.00
4,406.00
4,910.00
5,527.00
5,327.00
Gross Income
508.00
1,587.00
709.00
977.00
1,468.00
SG&A Expense
3,058.00
3,533.00
4,054.00
3,849.00
4,507.00
EBIT
2,550.00
-
3,345.00
2,662.00
2,844.00
Non Operating Income/Expense
592.00
282.00
4,939.00
120.00
55.80
Interest Expense
42.00
256.00
268.00
21.00
312.20
Pretax Income
1,973.00
1,882.00
1,346.00
2,789.00
3,212.00
Income Tax
19.00
52.00
13.00
704.00
786.00
Consolidated Net Income
1,992.00
1,830.00
1,333.00
2,085.00
3,998.00
Net Income
1,992.00
1,830.00
1,333.00
2,085.00
3,998.00
Net Income After Extraordinaries
1,992.00
1,830.00
1,333.00
2,085.00
3,998.00
Net Income Available to Common
1,992.00
1,830.00
1,333.00
2,085.00
3,998.00
EPS (Basic)
0.26
0.23
0.14
0.20
0.33
Basic Shares Outstanding
7,533.80
8,006.10
9,725.80
10,744.90
12,123.00
EPS (Diluted)
0.26
0.23
0.14
0.19
0.33
Diluted Shares Outstanding
7,533.80
8,006.10
9,725.80
10,744.90
12,123.00
EBITDA
2,182.00
1,399.00
2,812.00
2,144.00
2,224.00
Other Operating Expense
-
-
-
210.00
195.00
Non-Operating Interest Income
27.00
38.00
20.00
14.00
-

About Curasan

View Profile
Address
Lindigstraße 4
Aschaffenburg Bayern (Bavaria) 63801
Germany
Employees -
Website http://www.curasan.de
Updated 09/14/2018
curasan AG engages in the developing, manufacturing and marketing of regenerative medicine. Its products cover the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. The company was founded by Hans Dieter Rössler in 1988 and is headquartered in Aschaffenburg, Germany.